BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 8059236)

  • 1. Cutaneous expressions of antiphospholipid syndromes.
    Eng AM
    Semin Thromb Hemost; 1994; 20(1):71-8. PubMed ID: 8059236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiphospholipid antibodies in systemic lupus erythematosus and Sneddon's syndrome.
    Söhngen D; Wehmeier A; Specker C; Schneider W
    Semin Thromb Hemost; 1994; 20(1):55-63. PubMed ID: 8059234
    [No Abstract]   [Full Text] [Related]  

  • 3. Cutaneous manifestations of antiphospholipid antibody syndrome.
    Weinstein S; Piette W
    Hematol Oncol Clin North Am; 2008 Feb; 22(1):67-77, vi. PubMed ID: 18207066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiphospholipid syndrome and cutaneous vasoocclusive disorders.
    Grattan CE; Burton JL
    Semin Dermatol; 1991 Sep; 10(3):152-9. PubMed ID: 1931563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of nonspecific cutaneous vascular lesions and association with antiphospholipid antibodies in patients with systemic lupus erythematosus.
    Hawro T; Maurer M; Sysa-Jędrzejowska A; Woźniacka A
    Br J Dermatol; 2013 Jan; 168(1):213-5. PubMed ID: 22646136
    [No Abstract]   [Full Text] [Related]  

  • 6. Livedo reticularis and pregnancy morbidity in patients negative for antiphospholipid antibodies.
    Sangle S; D'Cruz DP; Hughes GR
    Ann Rheum Dis; 2005 Jan; 64(1):147-8. PubMed ID: 15608315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Sneddon syndrome and antiphospholipid antibodies].
    Montalbán J
    Med Clin (Barc); 1988 Sep; 91(7):277. PubMed ID: 3193838
    [No Abstract]   [Full Text] [Related]  

  • 8. [Livedo reticularis, cerebrovascular disorders and mitral disease: a new cause of Sneddon's syndrome?].
    Vaillant L; Larmande P; Arbeille B; Desveaux B; Gruel Y; Lorette G
    Ann Dermatol Venereol; 1990; 117(12):925-30. PubMed ID: 2082786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dermatologic manifestations of the antiphospholipid syndrome: two hundred consecutive cases.
    Francès C; Niang S; Laffitte E; Pelletier Fl; Costedoat N; Piette JC
    Arthritis Rheum; 2005 Jun; 52(6):1785-93. PubMed ID: 15934071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cerebrovascular disorders associated with livedo (Sneddon's syndrome): its relation to lupus anticoagulant].
    Kalashnikova LA; Prudnikova LZ; Nasonov EP
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1990; 90(7):104-7. PubMed ID: 2175072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Sneddon's syndrome and antiphospholipid antibodies].
    Pérez Sempere A; Martínez Menéndez B; Bermejo F
    Neurologia; 1992 Nov; 7(9):280-1. PubMed ID: 1445719
    [No Abstract]   [Full Text] [Related]  

  • 12. Familial Sneddon's syndrome: clinical, hematologic, and radiographic findings in two brothers.
    Pettee AD; Wasserman BA; Adams NL; McMullen W; Smith HR; Woods SL; Ratnoff OD
    Neurology; 1994 Mar; 44(3 Pt 1):399-405. PubMed ID: 8145905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiphosphatidylethanolamine antibodies as the only antiphospholipid antibodies. I. Association with thrombosis and vascular cutaneous diseases.
    Berard M; Chantome R; Marcelli A; Boffa MC
    J Rheumatol; 1996 Aug; 23(8):1369-74. PubMed ID: 8856615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiphosphatidylethanolamine antibodies as the only antiphospholipid antibodies detected by ELISA. II. Kininogen reactivity.
    Boffa MC; Berard M; Sugi T; McIntyre JA
    J Rheumatol; 1996 Aug; 23(8):1375-9. PubMed ID: 8856616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lupoid sclerosis: what is the role of antiphospholipid antibodies?
    Lima I; Melo A; Brandi IV; Costa O; Santiago M
    J Clin Rheumatol; 2007 Apr; 13(2):85-6. PubMed ID: 17414536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Sneddon syndrome as a clinical manifestation of the antiphospholipid antibody syndrome].
    Mojzes J; Battyáni Z; Grexa E
    Orv Hetil; 1993 Jan; 134(5):251-5. PubMed ID: 8426732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anetoderma in systemic lupus erythematosus: relationship to antiphospholipid antibodies.
    Montilla C; Alarcón-Segovia D
    Lupus; 2000; 9(7):545-7. PubMed ID: 11035422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cutaneous manifestations of systemic lupus erythematosus.
    Yell JA; Mbuagbaw J; Burge SM
    Br J Dermatol; 1996 Sep; 135(3):355-62. PubMed ID: 8949425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparative analysis of clinical and laboratory charactiristics of antiphospholipid syndrome].
    Soltész P; Veres K; Kiss E; Lakos G; Sonkoly I; Muszbek L; Szegedi G
    Orv Hetil; 2000 Dec; 141(52):2821-5. PubMed ID: 11202118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Sneddon's syndrome vasculopathy with antiphospholipid antibodies in a child].
    Villaizán C; Ferrada MJ; Legarda I; Iriarte J; Narbona J; Martínez-Lage JM
    Neurologia; 1995 Jan; 10(1):41-5. PubMed ID: 7893511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.